InVivo Therapeutics Holdings - Delisted Stock
InVivo Therapeutics Holdings is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day InVivo Therapeutics was actively traded.
Valuation
Check how we calculate scores
InVivo Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. InVivo Therapeutics market risk premium is the additional return an investor will receive from holding InVivo Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in InVivo Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although InVivo Therapeutics' alpha and beta are two of the key measurements used to evaluate InVivo Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 8.56 | |||
| Semi Deviation | 11.61 | |||
| Standard Deviation | 20.62 | |||
| Variance | 425.19 |
View InVivo Therapeutics Related Equities
| Risk & Return | Correlation |
InVivo Therapeutics Corporate Directors
InVivo Therapeutics corporate directors refer to members of an InVivo Therapeutics board of directors. The board of directors generally takes responsibility for the InVivo Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of InVivo Therapeutics' board members must vote for the resolution. The InVivo Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jeffrey Hatfield | Director | Profile | |
| Ann Merrifield | Director | Profile | |
| Kenneth Pietro | Independent Director | Profile | |
| Richard Roberts | Independent Director | Profile |
Still Interested in InVivo Therapeutics Holdings?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |